We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.5B
AUM Growth
+$2.94B
Cap. Flow
+$1.45B
Cap. Flow %
9.35%
Top 10 Hldgs %
30.63%
Holding
2,230
New
735
Increased
384
Reduced
378
Closed
720

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$614M
2
AAPL icon
Apple
AAPL
+$443M
3
BLD
TopBuild
BLD
+$391M
4
SPCX
SpaceX
SPCX
+$329M
5
PEN icon
Penumbra
PEN
+$203M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.96B
2
NVDA icon
NVIDIA
NVDA
+$425M
3
SNDK
Sandisk
SNDK
+$88M
4
SO icon
Southern Company
SO
+$80.6M
5
PPL
PPL Corp
PPL
+$74.1M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Industrials 13.64%
3 Consumer Discretionary 9.5%
4 Healthcare 7.9%
5 Financials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYBT icon
2051
Stock Yards Bancorp
SYBT
$2.55B
-48,537
Closed -$3.22M
SYRE icon
2052
Spyre Therapeutics
SYRE
$9.39B
-87,065
Closed -$4.39M
TALO icon
2053
Talos Energy
TALO
$2.92B
-136,673
Closed -$2.15M
TARA icon
2054
Protara Therapeutics
TARA
$228M
-116,305
Closed -$606K
TCBK icon
2055
TriCo Bancshares
TCBK
$1.76B
-8,542
Closed -$406K
TDC icon
2056
Teradata
TDC
$2.58B
-139,550
Closed -$3.58M
TERN
2057
CALL
DELISTED
Terns Pharmaceuticals
TERN
-153,400
Closed -$8.09M
TERN
2058
DELISTED
Terns Pharmaceuticals
TERN
-80,245
Closed -$4.23M
TFX icon
2059
Teleflex
TFX
$5.88B
-113,052
Closed -$13.5M
TGB
2060
Trekor Metals
TGB
$3.36B
-10,139
Closed -$65.4K
TGT icon
2061
Target
TGT
$75.1B
-67,552
Closed -$8.58M
THG icon
2062
Hanover Insurance
THG
$7.77B
-14,837
Closed -$2.57M
THO icon
2063
Thor Industries
THO
$4.14B
-34,032
Closed -$2.72M
TIPT icon
2064
Tiptree Inc
TIPT
$675M
-36,377
Closed -$615K
TK icon
2065
Teekay
TK
$1.16B
-24,349
Closed -$297K
TKNO icon
2066
Alpha Teknova
TKNO
$395M
-10,743
Closed -$31K
TLRY icon
2067
Tilray
TLRY
$666M
-40,990
Closed -$265K
TME icon
2068
Tencent Music
TME
$14.4B
-14,043
Closed -$130K
TOL icon
2069
Toll Brothers
TOL
$13.7B
-101,110
Closed -$13.8M
TPG icon
2070
TPG
TPG
$8.74B
-36,487
Closed -$1.48M
TRC icon
2071
Tejon Ranch
TRC
$444M
-14,627
Closed -$276K
TRGP icon
2072
Targa Resources
TRGP
$64.1B
-79,608
Closed -$20M
TRST
2073
Trustco Bank Corp NY
TRST
$968M
-11,505
Closed -$504K
TRVI icon
2074
Trevi Therapeutics
TRVI
$2.56B
-79,859
Closed -$953K
TSCO icon
2075
Tractor Supply
TSCO
$18.2B
-389,550
Closed -$17.6M

Similar funds

Michael Gelband's Q2 2026 Portfolio in Review

As of Q2 2026, Michael Gelband held 2,230 positions worth $15.5B, up 23% from $12.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael Gelband deployed $1.45B of net new capital in Q2 2026, opening 735 new positions and adding to 384 existing holdings. Its largest new stake was SpaceX: 1,938,935 shares worth $331M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $1.96B trimmed.

  • Michael Gelband's largest Q2 2026 buy was SpaceX: 1,938,935 shares worth $331M.
  • Michael Gelband added most to Amazon in Q2 2026, an estimated $614M increase.
  • Michael Gelband's biggest Q2 2026 reduction was Tesla, cutting an estimated $1.96B.
  • Michael Gelband fully exited Southern Company in Q2 2026, selling an estimated $80.6M.
  • Michael Gelband's ten largest holdings make up 31% of its $15.5B portfolio in Q2 2026.
  • Michael Gelband opened 735 new positions and closed 720 in Q2 2026.
  • Michael Gelband's portfolio value rose 23% quarter-over-quarter to $15.5B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.